Metalyse 5'000 U

Metalyse 5'000 U is a medicine authorised by Swissmedic under authorisation number 69958. The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 August 2025 and the authorisation is limited until 17 August 2030. ATC code B01AD11 places the medicine in the group Antithrombotic agents.

  • Dispensing category B
  • Authorisation number 69958
  • ATC B01AD11
  • Biotechnological medicines
Authorisation data
Authorisation number69958
NameMetalyse 5'000 U
Full nameMetalyse 5'000 U, Pulver zur Herstellung einer Injektionslösung
Authorisation holderBoehringer Ingelheim (Schweiz) GmbH
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeB01AD11
First authorisation18 August 2025
Authorisation validity17 August 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Metalyse 5'000 U, Pulver zur Herstellung einer InjektionslösungB18 August 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)B01AD1106.05.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Metalyse 5'000 U authorised in Switzerland?

Yes. Metalyse 5'000 U is authorised by Swissmedic under authorisation number 69958, data as of 01 September 2026. The authorisation is limited until 17 August 2030.

Which dispensing category does Metalyse 5'000 U have?

Metalyse 5'000 U is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Metalyse 5'000 U?

The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com